Other Infections
Study Finds No XMRV-Chronic Fatigue Link
- Details
- Category: XMRV & Other Retroviruses
- Published on Tuesday, 10 May 2011 04:22
- Written by Liz Highleyman
Analysis of blood samples from 300 people in Utah did not show an association between chronic fatigue syndrome and infection with XMRV retrovirus.
Lopinavir Fights HPV in Cervical Cancer Cells
- Details
- Category: Human Papillomavirus (HPV)
- Published on Thursday, 05 May 2011 18:26
- Written by University of Manchester
The HIV protease inhibitor lopinavir (the main drug in Kaletra) blocked viral proteasome activitation and selectively killed pre-cancerous cervical cells infected with human papillomavirus (HPV).
As reported in the May 3, 2011, advance online edition of Antiviral Therapy, Gavin Batman and Ian Hampson from the University of Manchester in the U.K. and colleagues tested lopinavir in HPV-infected SiHa cervical carcinoma cells in a laboratory study.
Genital Herpes Virus Can Spread Despite Lack of Symptoms
- Details
- Category: Herpes
- Published on Saturday, 23 April 2011 05:17
- Written by Liz Highleyman
People without genital sores or other symptoms can still shed and transmit herpes simplex virus type 2 (HSV-2) during sex, according to a recent U.S. study. 
Researchers Develop HPV Protein Inhibitor
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 03 May 2011 05:40
- Written by Tufts
Researchers constructed a recombinant protein that interferes with the human papillomavirus (HPV) E2 protein, inhibiting viral replication and its ability to cause cancer. 
TB Fixed-dose Coformulation Works as Well as Separate Drugs
- Details
- Category: Tuberculosis (TB)
- Published on Friday, 15 April 2011 06:57
- Written by Liz Highleyman
A 4-drug combination containing rifampicin, isoniazid, pyrazinamide, and ethambutol treats pulmonary tuberculosis (TB) as effectively as individual medications.
FDA Approves New Human Papillomavirus Test
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 29 April 2011 05:26
- Written by FDA
The FDA this week approved Roche's new human papillomavirus test, which identifies genotypes of cancer-causing HPV types 16 and 18, as well as detecting 12 other high-risk types.
TB Fixed-dose Coformulation Works as Well as Separate Drugs
- Details
- Category: Tuberculosis (TB)
- Published on Thursday, 14 April 2011 23:06
- Written by Liz Highleyman
A 4-drug combination containing rifampicin, isoniazid, pyrazinamide, and ethambutol treats pulmonary tuberculosis (TB) as effectively as individual medications.
Anal Pap Screening of HIV+ Men Reveals Half Have Abnormal Cells
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 26 April 2011 04:50
- Written by HIVandHepatitis.com
More than 80% of HIV positive men agreed to undergo Pap screening for anal cancer, demonstrating its feasibility, and 53% showed signs of potentially pre-cancerous abnormal cell growth.
CROI 2011: HPV and Anal Cancer Research at CROI 2011
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 01 April 2011 00:58
- Written by Matt Sharp
Human papillomavirus (HPV) infection remains common among people with HIV and anal cancer is still potentially deadly, researchers reported at CROI 2011. 
Web Design and Development by